• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 76 of 100
New England Towns Struggle With Opioid And Heroin Epidemic
HealthOxyContin’s 12-Hour Dosing Claim Attacked In Massive Investigation
By Sy MukherjeeMay 6, 2016
Fortune Brainstorm Tech 2015
FinanceDiabetes ‘Unicorn’ Intarcia Hits Major Milestone
By Dan PrimackMay 6, 2016
The Powerful And Influential Attend Clinton Global Initiative Annual Meeting
HealthMerck CEO: We’re on the Hunt for Deals in 2016
By Sy MukherjeeMay 6, 2016
The headquarters of Valeant Pharmaceuticals International, Inc. stands in Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
HealthValeant Says it Has a New Way to Ensure it Doesn’t Price Gouge So Much
By ReutersMay 6, 2016
Sanofi Threatens to Oust Drugmaker Medivation’s Board If It Won’t Talk Merger
HealthSanofi Threatens to Oust Drugmaker Medivation’s Board If It Won’t Talk Merger
By ReutersMay 6, 2016
Inside The Pfizer Inc. Kendall Square Research Facility Ahead Of Earnings Figures
HealthNow It’s Pfizer That Wants to Buy Cancer Drug Maker Medivation
By ReutersMay 4, 2016
Stocks Close Sharply Lower As Oil Prices Continue Decline
FinanceThese Biopharma Companies Are the World’s Top Shareholder Value Creators
By Sy MukherjeeMay 3, 2016
172646513
HealthU.S. Approves First Drug for Psychosis Linked to Parkinson’s
By ReutersApril 30, 2016
493534821
HealthBig Pharma Under Pressure to Pay For Drug Take-Back Programs
By Sy MukherjeeApril 30, 2016
A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange
FinanceAbbVie Buying Cancer Drug Startup Stemcentrx for $10.2 Billion
By Dan PrimackApril 28, 2016
Sanofi Just Made a Hostile $9.3 Billion Bid for This San Francisco Drugmaker
HealthSanofi Just Made a Hostile $9.3 Billion Bid for This San Francisco Drugmaker
By ReutersApril 28, 2016
Squawk Box - Season 20
FinanceBill Ackman: Valeant’s Drug Price Hikes Hurt America
By Sy MukherjeeApril 27, 2016
547016547
HealthWhy Biogen Is Poaching This Pfizer Exec to Head Up Its R&D Shop
By Sy MukherjeeApril 27, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
LeadershipValeant CEO to Tell Senate Jacking Up Heart Drug Prices Was a ‘Mistake’
By ReutersApril 27, 2016
Here’s How Drug Prices Actually Work
FinanceHere’s How Drug Prices Actually Work
By Lauren Silva LaughlinApril 26, 2016
1...
  • 74
  • 75
  • 76
  • 77
  • 78
...100
Most Popular
Future of Work
'Employers are increasingly turning to degree and GPA' in hiring: Recruiters retreat from ‘talent is everywhere,’ double down on top collegesplaceholder alt text
By Jake AngeloMay 9, 2026
Politics
Ted Cruz says the quiet part out loud: Trump accounts are Social Security personal accounts as GOP senator reveals 'dirty little secret'placeholder alt text
By Jason MaMay 9, 2026
Economy
‘This is the way’: Elon Musk endorses Warren Buffett’s famed 5-minute plan to fix the national debtplaceholder alt text
By Jacqueline MunisMay 10, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.